Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis

QR-koodi

Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis

https://trepo.tuni.fi/handle/10024/119790

http://www.urn.fi/URN:NBN:fi:tuni-202002212278

Ocrelizumab_versus_interferon_2017.pdf (Tampereen yliopisto - Trepo)

Teksti

Hauser, Stephen L. ; Bar-Or, Amit ; Comi, Giancarlo ; Giovannoni, Gavin ; Hartung, Hans-Peter ; Hemmer, Bernhard ; Lublin, Fred ; Montalban, Xavier ; Rammohan, Kottil W. ; Selmaj, Krzysztof ; Traboulsee, Anthony ; Wolinsky, Jerry S. ; Arnold, Douglas L. ; Klingelschmitt, Gaelle ; Masterman, Donna ; Fontoura, Paulo ; Belachew, Shibeshih ; Chin, Peter ; Mairon, Nicole ; Garren, Hideki ; Kappos, Ludwig ; Elovaara, Irina ; for the OPERA I and OPERA II Clinical Investigators ; Lääketieteen ja biotieteiden tiedekunta - Faculty of Medicine and Life Sciences ; Tampere University

2017

Tallennettuna:

Kieli

englanti

ISSN

1533-4406

Henkilökuntanäyttö